The First Post-IPR Director Reviews are Denied
Patently-O
AUGUST 4, 2021
One of the topics to be discussed at tomorrow’s PPAC meeting is USPTO operations following the Supreme Court’s 2021 Arthrex decision. In Arthrex , the Supreme Court created an additional layer of review by the PTO Director in Inter Partes Review (IPR) proceedings following a PTAB final written decision.
Let's personalize your content